The Potential of Semaglutide Once-Weekly in Patients Without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss After Bariatric Surgery-a Retrospective Analysis.
Anne LautenbachMarie WerneckeTobias B HuberFabian StollJonas WagnerSebastian M MeyhöferSvenja MeyhöferJens AberlePublished in: Obesity surgery (2022)
Treatment options to manage post-bariatric excess weight (regain) are scarce. Our results imply a clear benefit of adjunct treatment with semaglutide in post-bariatric patients. However, these results need to be confirmed in a prospective randomized controlled trial to close the gap between lifestyle intervention and revision surgery in patients with IWL or WR after BS.
Keyphrases
- weight loss
- randomized controlled trial
- end stage renal disease
- type diabetes
- gastric bypass
- bariatric surgery
- roux en y gastric bypass
- chronic kidney disease
- newly diagnosed
- ejection fraction
- physical activity
- prognostic factors
- peritoneal dialysis
- cardiovascular disease
- weight gain
- patient reported outcomes
- systematic review
- study protocol
- patient reported
- adipose tissue
- percutaneous coronary intervention